AS
BMRN icon

Aware Super’s BioMarin Pharmaceuticals BMRN Stock Holding History

Aware Super’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$22M Buy
405,767
+50,857
+14% +$2.91M 0.3% 93
2025
Q2 		$19.5M Buy
+354,910
New +$20.9M 0.29% 99

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Aware Super's BMRN Position: Q3 2025 in Review

Aware Super increased its BioMarin Pharmaceuticals (BMRN) stake by 14% in Q3 2025, buying an estimated $2.91M and bringing the position to 405,767 shares worth $22M. The position accounts for 0.3% of the portfolio, ranked #93.

Aware Super first reported a position in BMRN in Q2 2025 and has held it in 2 quarters since. 576 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Aware Super held 405,767 shares of BioMarin Pharmaceuticals worth $22M as of Q3 2025.
  • Aware Super bought 50,857 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $2.91M.
  • BioMarin Pharmaceuticals made up 0.3% of Aware Super's portfolio in Q3 2025, its #93 holding.
  • Aware Super first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 576 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Aware Super's 13F filing for Q3 2025, filed 13 Nov 2025.